¼º¼®ÁÖ
¼Ò
¼Ó
: °³²Â÷º´¿ø
Àü¹®ºÐ¾ß : ºÎÀξÏ, ÀڱñÙÁ¾, ³¼ÒÁ¾¾ç,·Îº¿¼ö¼ú, º¹°°æ,Àڱðæ, ´ÜÀÏ°ø¼ö¼ú
Á÷
ˤ
: ±³¼ö
¸Þ
ÀÏ
:
.
Àü
È
:
02.3468.3000
ÆÑ
½º
:
02.558.1119
ÁÖ
¼Ò
:
¼¿ï½Ã °³²±¸ ¿ª»ï1µ¿ 650-9
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
54
ÇØ¿Ü
Rapid recurrence of uterine smooth muscle tumor of uncertain malignant potential as leiomyosarcoma.
53
ÇØ¿Ü
Management of Endometrial Hyperplasia With a Levonorgestrel-releasing Intrauterine System: Single Arm, Prospective Multicenter Study: Korean Gynecologic Oncology Group Study (KGOG2006).
52
±¹³»
º¹°°æÇÏ ±ÙÁ¾ÀýÁ¦¼ú ½Ã misoprostol ÀüóġÀÇ È¿°ú
51
±¹³»
ºÎÀΰú Áúȯ¿¡¼ÀÇ ¹Ì·¹³ª¢çÀÇ ÀÓ»óÀû È°¿ë
50
ÇØ¿Ü
Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: pilot study.
49
ÇØ¿Ü
Should diagnostic laparoscopy be conducted before hormonal treatment in early-stage endometrial cancer?
48
ÇØ¿Ü
Short-term results of magnetic resonance imaging-guided focused ultrasound surgery for patients with adenomyosis: symptomatic relief and pain reduction.
47
±¹³»
A case of ovarian microinvasive mucinous carcinoma and co-existent angiosarcoma.
46
ÇØ¿Ü
Prevalence and predictors of anxiety and depression among cervical cancer survivors in Kore
45
ÇØ¿Ü
The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women
1
2
3
4
5
6
7
8
9
10
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729